Amphastar Pharmaceuticals is Drug Delivery in United States that focus on Amphastar Pharmaceuticals Inc business. Founded in 1996. They cover business area such as Amphastar Pharmaceuticals Inc, manufacturing, marketing, two reportable segment, namely finished pharmaceutical product, API product, enoxaparin, naloxone, lidocaine, RHI API, porcine insulin API, its product, hospital, urgent care clinical setting, France, revenue.
1996
( 30 years old in 2026 )
Amphastar Pharmaceuticals Inc
-
11570 6th Street
Rancho Cucamonga, CA 91730
United States
Private
Amphastar Pharmaceuticals Incmanufacturingmarketingtwo reportable segmentnamely finished pharmaceutical productAPI productenoxaparinnaloxonelidocaineRHI APIporcine insulin APIits producthospitalurgent care clinical settingFrancerevenue
* We use standard office opening hours in near Amphastar Pharmaceuticals's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Amphastar Pharmaceuticals is Drug Delivery business from United States that founded in 1996 (30 years old in 2026), Amphastar Pharmaceuticals business is focusing on Amphastar Pharmaceuticals Inc.
Amphastar Pharmaceuticals headquarter office and corporate office address is located in 11570 6th Street Rancho Cucamonga, CA 91730 United States.
Amphastar Pharmaceuticals was founded in United States.
In 2026, Amphastar Pharmaceuticals is currently focus on Amphastar Pharmaceuticals Inc sector.
Above is snippet of Google Trends for "Amphastar Pharmaceuticals Inc" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Amphastar Pharmaceuticals, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
